Skip to main content

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ENPH, CODX and WINS

NEW YORK, NY / ACCESSWIRE / August 5, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Enphase Energy, Inc. (NASDAQ:ENPH)
Class Period: February 26, 2019 - June 17, 2020
Lead Plaintiff Deadline: August 17, 2020

During the class period, Enphase Energy, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ENPH: http://www.kleinstocklaw.com/pslra-1/enphase-energy-inc-loss-submission-form?id=8384&from=1

Co-Diagnostics, Inc. (NASDAQ:CODX)
Class Period: February 25, 2020 - May 15, 2020
Lead Plaintiff Deadline: August 17, 2020

According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company's main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics' stock, while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics' fraudulent misstatements displayed a disregard for basic scientific principles and caused investors to lose millions of dollars.

Learn about your recoverable losses in CODX: http://www.kleinstocklaw.com/pslra-1/co-diagnostics-inc-loss-submission-form?id=8384&from=1

Wins Finance Holdings Inc. (NASDAQ:WINS)
Class Period: October 31, 2018 - July 6, 2020
Lead Plaintiff Deadline: September 23, 2020

The complaint alleges that during the class period Wins Finance Holdings Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the ultimate repayment of the RMB 580 million Guohong Loan was highly uncertain; (ii) nonpayment of the Guohong Loan would have a significant impact on the Company's financial and operating condition; (iii) weaknesses in Wins's internal control over its financial reporting persisted despite the Company's repeated assurances to investors that it was taking steps to remediate these weaknesses; (iv) the foregoing issues, among others, made the resignation of Wins's independent auditor foreseeably likely; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in WINS: http://www.kleinstocklaw.com/pslra-1/wins-finance-holdings-inc-loss-submission-form?id=8384&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/600439/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-ENPH-CODX-and-WINS

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.